Zevra Therapeutics Inc (ZVRA) returns
Zevra Therapeutics returns over 10 years
$1,000 invested in Zevra Therapeutics ten years ago was worth $169.08 at the close on October 30, 2026, with dividends reinvested: an average return of -16.3% a year. The same $1,000 in the S&P 500 (SPY) became $4,166.
Total return by period
| Period | Total return | A year, on average | $1,000 became | S&P 500 (SPY) |
|---|---|---|---|---|
| 1 month | -6.3% | — | $937.10 | -0.9% |
| 3 months | +6.6% | — | $1,066 | +2.1% |
| Year to date | +14.7% | — | $1,147 | +11.7% |
| 1 year | +1.4% | — | $1,014 | +12.4% |
| 3 years | +137.4% | +33.4% | $2,374 | +88.5% |
| 5 years | +8.2% | +1.6% | $1,082 | +76.0% |
| 10 years | -83.1% | -16.3% | $169.08 | +316.6% |
Zevra Therapeutics return by calendar year
| Year | ZVRA | S&P 500 (SPY) | Difference |
|---|---|---|---|
| 2026 to date | +14.7% | +11.7% | +3.0% |
| 2025 | +7.4% | +17.7% | -10.3% |
| 2024 | +27.3% | +24.9% | +2.4% |
| 2023 | +42.7% | +26.2% | +16.5% |
| 2022 | -47.3% | -18.2% | -29.1% |
| 2021 | -22.2% | +28.7% | -51.0% |
| 2020 | +84.7% | +18.4% | +66.3% |
| 2019 | -78.7% | +31.2% | -109.9% |
| 2018 | -56.0% | -4.6% | -51.5% |
| 2017 | +37.3% | +21.7% | +15.6% |
| 2016 | -85.1% | +12.0% | -97.1% |
Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.
See also: ZVRA financials · ZVRA valuation
No forecast, no recommendation. This page describes Zevra Therapeutics Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.